• Study of Dostarlimab for Patients with Advanced or Metastatic Non-Colorectal/Non-Endometrial Cancer with dMMR/MSI, Compared to Standard Drug Combination

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France
  • Study on Beta-Blockers for Patients with Takotsubo Syndrome: Evaluating Selective, Non-Selective, and Alpha-Beta Blocking Agents

    Recruiting

    3 1 1 1
    Spain
  • Oxygen Therapy for Pregnant Women to Support Heart Development in Unborn Babies with Underdeveloped Left Heart Structures

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Germany
  • Study Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Study on Preventing Infections After Esophageal Cancer Surgery Using Colistin Sulfate, Tobramycin, and Amphotericin B in Patients with Resectable Esophageal Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium The Netherlands
  • Study of LN-145 (Tumor Infiltrating Lymphocytes) in patients with metastatic non-small-cell lung cancer

    Recruiting

    2 1 1 1
    Belgium France Germany Italy The Netherlands Spain
  • Long-term Safety and Efficacy Study of JR-141 (Pabinafusp Alfa) for Male Patients with Hunter Syndrome (Mucopolysaccharidosis II)

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Italy Poland Spain
  • Study on the Effects of Iloprost Trometamol in Patients with Infectious Lung Disease on Mechanical Ventilation

    Recruiting

    2 1 1
    Investigated Diseases:
    Denmark
  • Study on the Use of 18F-PSMA-1007, Hyoscine Butylbromide, and Gadoteric Acid in Imaging for Patients with High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Sweden
  • Study Comparing Trametinib and Vinblastine for Children and Young Adults with Newly Diagnosed Low-Grade Glioma with Wild-Type BRAF Gene

    Recruiting

    2 1 1 1
    Investigated Diseases:
    France

powered by